Management of Infected Pancreatic Necrosis
Diagnosis and Treatment
- Suspected infection is based on clinical deterioration, signs of sepsis, or persistent organ failure 6-10 days after admission, and all patients with infected necrosis require intervention to completely debride all cavities containing necrotic material 1
- All patients with severe acute pancreatitis should be managed in a high dependency unit or intensive care unit with full monitoring and systems support, including peripheral venous access, central venous line, urinary catheter, and nasogastric tube, and regular monitoring of vital signs, with strict asepsis observed in the placement and care of invasive monitoring equipment, as recommended by the Gut society 2, 1
- Prompt diagnosis of infection is crucial for timely intervention, and delayed diagnosis can lead to poor outcomes, with confirmation of infected necrotic pancreatitis done through methods such as CT-guided fine-needle aspiration (FNA) with positive Gram stain and culture, presence of gas in retroperitoneal area on CT imaging, clinical signs of infection, and elevated serum markers (e.g. procalcitonin) 3, 4, 5, 2
- Asymptomatic fluid collections should not be drained, and appropriate drainage is essential for antibiotic efficacy, with a "step-up" approach (Delay, Drain, Debride) recommended for source control, following the 3Ds, as recommended by the World Journal of Emergency Surgery and the European Society of Gastrointestinal Endoscopy 6, 4, 3, 2
Antibiotic Therapy
- The first-line antibiotic for infected pancreatic necrosis is Carbapenems (e.g. meropenem 1g q6h by extended infusion), with alternative options including Doripenem, imipenem/cilastatin, meropenem/vaborbactam, or eravacycline 1mg/kg q12h, as recommended by the Infectious Diseases Society of America and the World Journal of Emergency Surgery 3, 4, 6, 5, 2
- The standard duration of antibiotic treatment is 4-7 days with adequate source control, and treatment should be re-evaluated if signs of infection persist beyond 7 days, as recommended by the American Gastroenterological Association and the European Society of Gastrointestinal Endoscopy 3, 4, 7, 5, 6, 2
- Prolonged antibiotic treatment (>15 days) increases the risk of developing antibiotic-resistant infections, and prophylactic antibiotics should be avoided in sterile necrosis, as recommended by the American Gastroenterological Association and the European Society of Gastrointestinal Endoscopy 3, 4, 6, 5, 2
- Current guidelines do not support routine prophylactic antibiotics for sterile necrosis, and the American Gastroenterological Association recommends that antibiotics are not required routinely for mild acute pancreatitis, but are necessary for confirmed infected pancreatic necrosis, specific documented infections, and prophylaxis before invasive procedures 2, 8, 9
Antifungal Prophylaxis
- Routine prophylactic antifungals are not recommended, but consideration should be given to adding an echinocandin in high-risk patients with prolonged antibiotic exposure, as recommended by the Infectious Diseases Society of America and the World Journal of Emergency Surgery 6, 4, 5, 2
| Recommendation | Antibiotic/Antifungal | Duration |
|---|---|---|
| First-line antibiotic | Carbapenems (e.g. meropenem) | 4-7 days |
| Alternative antibiotics | Doripenem, imipenem/cilastatin, meropenem/vaborbactam | 4-7 days |
| Antifungal prophylaxis | Echinocandin (in high-risk patients) | As needed |
| Re-evaluation | If signs of infection persist beyond 7 days | - |
Multidisciplinary Approach
- The management of infected necrotizing pancreatitis requires a multidisciplinary approach involving gastroenterologists, surgeons, interventional radiologists, and infectious disease specialists to optimize outcomes and reduce mortality, with recommendations from various medical societies emphasizing the importance of evidence-based decision-making 6, 4, 3, 2